Kentucky 2026 Regular Session

Kentucky Senate Bill SB190

Introduced
2/12/26  

Caption

AN ACT relating to chronic pain treatments.

Impact

The legislation could significantly alter healthcare practices concerning chronic pain in Kentucky. By mandating coverage for alternative treatments, SB190 aims to reduce reliance on opioid prescriptions among patients suffering from chronic pain syndromes. This is particularly relevant in the context of growing concerns about opioid addiction and the need for safer pain management options. Moreover, the bill’s provisions could foster increased use of complementary and alternative medicines, which may lead to improved patient outcomes and satisfaction.

Summary

SB190 introduces a framework for managing chronic pain treatments within health benefit plans in Kentucky. The bill mandates that health insurance policies must cover up to twenty visits for various chronic pain management treatments, including acupuncture, chiropractic services, and physical therapy. This legislative act is designed to improve access to alternative pain management therapies, enabling patients to seek effective treatment without first having to consult a traditional healthcare provider. It emphasizes a direct approach, allowing patients to choose specialized professionals for their chronic pain management needs.

Sentiment

The general sentiment surrounding SB190 appears to be supportive, particularly among advocates for alternative medicine and pain management specialists. Proponents view the bill as a progressive step towards enhancing patient autonomy in healthcare choices and reducing the stigma related to non-traditional medical treatments. However, concerns have also been raised regarding the potential increase in healthcare costs for insurers and the necessity for rigorous oversight to ensure quality and safety in the application of these alternative treatments.

Contention

Despite the support, there are points of contention regarding the bill's implementation and regulation. Critics express skepticism about the adequacy of oversight for non-traditional treatments that may not be as rigorously evaluated as mainstream medical practices. Furthermore, questions arise about the cost implications for insurance companies and whether these changes may lead to increased premiums for the insured population as services expand. Engaging with skeptics and articulating clear regulatory frameworks will be essential to mitigate these concerns.

Companion Bills

No companion bills found.

Previously Filed As

KY HB506

AN ACT relating to chronic pain treatments.

KY HB531

AN ACT relating to chemical dependency treatment.

KY HB305

AN ACT relating to health care.

KY SB128

AN ACT relating to utilization controls for nonopioid analgesics in the Medicaid program.

KY HB389

AN ACT relating to prescription drugs.

KY HB426

AN ACT relating to youth mental health protection and declaring an emergency.

KY HB710

AN ACT relating to licensees authorized to prescribe or dispense controlled substances.

KY HB683

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY SB41

AN ACT relating to sickle cell disease.

KY HB419

AN ACT relating to reproductive privacy.

Similar Bills

AZ SB1244

Court-ordered treatment; continuation

AZ HB2944

Inpatient treatment days; computation; exclusion

AZ HB2706

Mental health; intensive treatment orders

CA AB1879

Substance use: treatment or residential data reporting.

CA AB2538

Medi-Cal: hospice providers: forms.

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)

HI SB2292

Relating To Workers' Compensation Medical Treatment.